Press Release Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives Aug 3
Press Release Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune Jul 22